These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 11990637)
1. Having an abortion using mifepristone and home misoprostol: a qualitative analysis of women's experiences. Fielding SL; Edmunds E; Schaff EA Perspect Sex Reprod Health; 2002; 34(1):34-40. PubMed ID: 11990637 [TBL] [Abstract][Full Text] [Related]
2. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. Honkanen H; Piaggio G; Hertzen H; Bártfai G; Erdenetungalag R; Gemzell-Danielsson K; Gopalan S; Horga M; Jerve F; Mittal S; Thi Nhu Ngoc N; Peregoudov A; Prasad RN; Pretnar-Darovec A; Shah RS; Song S; Tang OS; Wu SC; BJOG; 2004 Jul; 111(7):715-25. PubMed ID: 15198763 [TBL] [Abstract][Full Text] [Related]
3. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients]. Faucher P; Baunot N; Madelenat P Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206 [TBL] [Abstract][Full Text] [Related]
4. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone. Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414 [TBL] [Abstract][Full Text] [Related]
5. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation. Hamoda H; Ashok PW; Flett GM; Templeton A BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525 [TBL] [Abstract][Full Text] [Related]
6. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol. Guest J; Chien PF; Thomson MA; Kosseim ML BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893 [TBL] [Abstract][Full Text] [Related]
7. Home use of two doses of misoprostol after mifepristone for medical abortion: a pilot study in Sweden and France. Clark WH; Hassoun D; Gemzell-Danielsson K; Fiala C; Winikoff B Eur J Contracept Reprod Health Care; 2005 Sep; 10(3):184-91. PubMed ID: 16318966 [TBL] [Abstract][Full Text] [Related]
8. Women's perceptions on medical abortion. Ho PC Contraception; 2006 Jul; 74(1):11-5. PubMed ID: 16781253 [TBL] [Abstract][Full Text] [Related]
9. Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study. Jensen JT; Harvey SM; Beckman LJ Am J Obstet Gynecol; 2000 Jun; 182(6):1292-9. PubMed ID: 10871441 [TBL] [Abstract][Full Text] [Related]
10. [Study on Meta analysis regarding the acceptability of medical abortion compared with surgical abortion]. Zou Y; Liang Y; Wu SC; Li YP; Yan L; Mei L; Zhang JQ; Tong L Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Jan; 27(1):68-71. PubMed ID: 16737578 [TBL] [Abstract][Full Text] [Related]
11. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial. Shannon C; Wiebe E; Jacot F; Guilbert E; Dunn S; Sheldon WR; Winikoff B BJOG; 2006 Jun; 113(6):621-8. PubMed ID: 16709204 [TBL] [Abstract][Full Text] [Related]
12. Mifepristone and misoprostol for the treatment of early pregnancy failure: a pilot clinical trial. Schreiber CA; Creinin MD; Reeves MF; Harwood BJ Contraception; 2006 Dec; 74(6):458-62. PubMed ID: 17157102 [TBL] [Abstract][Full Text] [Related]
13. Abnormal expression of MMP-9 and imbalance of MMP-9/TIMP-1 is associated with prolonged uterine bleeding after a medical abortion with mifepristone and misoprostol. Li L; Zhou Z; Huang L Acta Obstet Gynecol Scand; 2009; 88(6):673-9. PubMed ID: 19353331 [TBL] [Abstract][Full Text] [Related]
14. Choice of and satisfaction with methods of medical and surgical abortion among U.S. clinic patients. Harvey SM; Beckman LJ; Satre SJ Fam Plann Perspect; 2001; 33(5):212-6. PubMed ID: 11589542 [TBL] [Abstract][Full Text] [Related]
15. Expanding medical abortion in Tunisia: women's experiences from a multi-site expansion study. Hajri S; Blum J; Gueddana N; Saadi H; Maazoun L; Chélli H; Dabash R; Winikoff B Contraception; 2004 Dec; 70(6):487-91. PubMed ID: 15541411 [TBL] [Abstract][Full Text] [Related]
16. Mobile phone messages to provide support to women during the home phase of medical abortion in South Africa: a randomised controlled trial. Constant D; de Tolly K; Harries J; Myer L Contraception; 2014 Sep; 90(3):226-33. PubMed ID: 24850188 [TBL] [Abstract][Full Text] [Related]
17. Mifepristone medical abortion in Albania: results from a pilot clinical research study. Bracken H; Gliozheni O; Kati K; Manoku N; Moisiu R; Shannon C; Tare V; Tasha I; Winikoff B; Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):38-46. PubMed ID: 16546815 [TBL] [Abstract][Full Text] [Related]
18. Understanding women's experiences with medical abortion: In-depth interviews with women in two Indian clinics. Ganatra B; Kalyanwala S; Elul B; Coyaji K; Tewari S Glob Public Health; 2010; 5(4):335-47. PubMed ID: 19431005 [TBL] [Abstract][Full Text] [Related]
19. Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol. Raghavan S; Comendant R; Digol I; Ungureanu S; Friptu V; Bracken H; Winikoff B Contraception; 2009 Feb; 79(2):84-90. PubMed ID: 19135563 [TBL] [Abstract][Full Text] [Related]
20. Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone. Arvidsson C; Hellborg M; Gemzell-Danielsson K Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):87-91. PubMed ID: 16260342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]